Phase I trial of CYT997, a novel cytotoxic and vascular-disrupting agent.
Lickliter JD, Francesconi AB, Smith G, Burge M, Coulthard A, Rose S, Griffin M, Milne R, McCarron J, Yeadon T, Wilks A, Cubitt A, Wyld DK, Vasey PA.
Lickliter JD, et al.
Br J Cancer. 2010 Aug 24;103(5):597-606. doi: 10.1038/sj.bjc.6605841.
Br J Cancer. 2010.
PMID: 20733579
Free PMC article.
Clinical Trial.